The trademark application LUPLUSMEA was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on February 27, 2020, and it was registered by office on June 5, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on September 27, 2020. A transfer of the trademark registration was recorded on February 9, 2022. A transfer of the trademark registration was recorded on December 5, 2022.